Hormonal Therapy
43 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.
Hormonal Therapy (43)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Giredestrant |
Selective Estrogen Receptor Degrader (SERD) | Solid Tumour (Breast) | ||
|
Molecule
Giredestrant
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
||||
Histrelin |
LHRH Agonist | Solid Tumour (Prostate/Breast) | ||
|
Molecule
Histrelin
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate/Breast)
Drug Class / Mechanism
LHRH Agonist |
||||
Imlunestrant |
Selective Estrogen Receptor Degrader (SERD) | Solid Tumour (Breast) | ||
|
Molecule
Imlunestrant
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
||||
Lasofoxifene |
Selective Estrogen Receptor Modulator (SERM) | Solid Tumour (Breast) | ||
|
Molecule
Lasofoxifene
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Modulator (SERM) |
||||
Letrozole |
Aromatase Inhibitor | Solid Tumour (Breast) | ||
|
Molecule
Letrozole
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
||||
Leuprolide Acetate |
LHRH Agonist | Solid Tumour (Prostate/Breast) | ||
|
Molecule
Leuprolide Acetate
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate/Breast)
Drug Class / Mechanism
LHRH Agonist |
||||
Medroxyprogesterone Acetate |
Progestin / Estrogen / Antiandrogen | Solid Tumour (Breast/Prostate/Endometrial) | ||
|
Molecule
Medroxyprogesterone Acetate
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
||||
Megestrol Acetate |
Progestin / Estrogen / Antiandrogen | Solid Tumour (Breast/Prostate/Endometrial) | ||
|
Molecule
Megestrol Acetate
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
||||
Nilutamide |
Antiandrogen | Solid Tumour (Prostate) | ||
|
Molecule
Nilutamide
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
Antiandrogen |
||||
Norethisterone (Onc Adjacent) |
Progestin / Estrogen / Antiandrogen | Solid Tumour (Breast/Prostate/Endometrial) | ||
|
Molecule
Norethisterone (Onc Adjacent)
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
||||
Orteronel |
CYP17 / Androgen Synthesis Inhibitor | Solid Tumour (Prostate) | ||
|
Molecule
Orteronel
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
CYP17 / Androgen Synthesis Inhibitor |
||||
Ospemifene (Onc Adjacent) |
Selective Estrogen Receptor Modulator (SERM) | Solid Tumour (Breast) | ||
|
Molecule
Ospemifene (Onc Adjacent)
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Modulator (SERM) |
||||
GiredestrantHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
|
HistrelinHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate/Breast)
Drug Class / Mechanism
LHRH Agonist |
|
ImlunestrantHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
|
LasofoxifeneHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Modulator (SERM) |
|
LetrozoleHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
|
Leuprolide AcetateHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate/Breast)
Drug Class / Mechanism
LHRH Agonist |
|
Medroxyprogesterone AcetateHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
|
Megestrol AcetateHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
|
NilutamideHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
Antiandrogen |
|
Norethisterone (Onc Adjacent)Hormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast/Prostate/Endometrial)
Drug Class / Mechanism
Progestin / Estrogen / Antiandrogen |
|
OrteronelHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate)
Drug Class / Mechanism
CYP17 / Androgen Synthesis Inhibitor |
|
Ospemifene (Onc Adjacent)Hormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Modulator (SERM) |
|